$89.75 +1.74 (1.98%)

LeMaitre Vascular, Inc. (LMAT)

LeMaitre Vascular, Inc. is a medical device company specializing in the development, manufacture, and commercialization of surgical solutions for peripheral vascular and cardiac use. Established to address the needs of vascular surgeons, the company offers a broad portfolio of products including vascular grafts, angioplasty balloons, stents, and other devices used in minimally invasive surgical procedures. LeMaitre Vascular serves a global customer base with an emphasis on improving patient outcomes through innovative technology.

Dividend Yield 0.85%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
September 4, 2025$0.202025-08-212025-08-21
May 29, 2025$0.202025-05-152025-05-15
March 27, 2025$0.202025-03-132025-03-13
December 5, 2024$0.162024-11-212024-11-21
August 29, 2024$0.162024-08-152024-08-15

Dividends Summary

Company News

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
GlobeNewswire Inc. • Lemaitre Vascular, Inc. • October 9, 2025

LeMaitre Vascular will release its third quarter 2025 financial results on November 6, 2025, after market close, with a conference call scheduled for 5:00 PM EST to discuss results and company outlook.

LeMaitre (LMAT) Q2 Revenue Jumps 15%
The Motley Fool • Jesterai • August 6, 2025

LeMaitre Vascular reported strong Q2 2025 financial results, with GAAP revenue of $64.2 million, exceeding estimates and growing 15% year-over-year. The company saw significant growth in catheters and grafts, expanded gross margins to 70%, and raised full-year guidance.

Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Zacks Investment Research • Zacks Equity Research • July 1, 2024

Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.

My Dividend Growth Portfolio
Seeking Alpha • The Dividend Guy • June 1, 2024

I split my holdings into two categories: a core portfolio generating dividend payments and a growth portfolio generating both dividend and stock value growth.

Navigating 4 Analyst Ratings For LeMaitre Vascular
Benzinga • Benzinga Insights • May 31, 2024

LeMaitre Vascular (NASDAQ:LMAT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish...